Reply To: observation time s/p asparaginase

  • Mary Conway Keller

    Member
    January 2, 2018 at 2:08 pm
    We follow the 1 hour post-infusion/administration observation as well.

    Mary Conway, RN, MSN, CPHON

    Pediatric Clinical Nurse Specialist

    Department of Hematology/Oncology

    Connecticut Children’s Medical Center

    282 Washington Street

    Hartford, CT 06106

    860-545-9630

    mxconway@connecticutchildrens.org

     

     

    **Connecticut Children’s Confidentiality Notice**
    This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure, or distribution is prohibited. If you are not the intended recipient, or an employee or agent responsible for delivering the message to the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message, including any attachments.

    ——Original Message——

    ​At my institution, we continue to monitor patients 1 hour post administration, regardless of route.  We base this practice off of the package insert for the drug, which specifies 1 hour monitoring and does not site a specific route for this recommendation.

    ——————————
    Kimberly Duback, MS, APN, PCNS-BC, CPN, CPHON
    Advanced Practice Nurse
    Advocate Children’s Hospital
    Oak Lawn, IL
    United States of America
    ——————————